
Patients with glioblastoma receiving temozolomide in the morning had an average overall survival of about 17 months, compared to an average overall survival of approximately 13.5 months for those taking the drug in the evening.

Patients with glioblastoma receiving temozolomide in the morning had an average overall survival of about 17 months, compared to an average overall survival of approximately 13.5 months for those taking the drug in the evening.

Although many attendees and presenters are looking forward to returning to in-person conferences in the future, Anne Krolikowski said the virtual format of their upcoming conference allows even more people to attend.

Staying educated in the formal and informal health care settings surrounding state-of-the-art cancer care in the community practice is essential for success.

Pet Peeves for March 2021, brought to you by The Sassy Pharmacist.

Indicators of the COVID-19 pandemic’s impact, including testing rates, positivity ratio, case rates by overall population, and deaths, are clustered by neighborhood, with low-income and predominantly minority communities experiencing worse outcomes.

The investigators concluded that pharmacies who use the patient engagement center are likely to see efficient operations and increased productivity.

FDA grants a fast track designation to GEN-1, a DNA-mediated IL-12 immunotherapy.

Based on their findings and considering the small size and portability of the test, the investigators said it could be used for fast virus detection in schools and airports.

According to previous studies, youth who are obese when they begin chemotherapy are more than twice as likely to have remaining cancer cells after 1 month of treatment compared to their lean counterparts.

Interactive case studies from March 2021.

Empiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.

The global rise of nonalcoholic fatty-liver disease in pediatric populations has highlighted the need to understand the potential cause of this growing trend.

Patricia Stinchfield, the president-elect of National Foundation for Infectious Diseases, discusses the recommended framework for vaccine messaging for leaders across sectors.

As hematology and oncology pharmacists have become increasingly essential members of the care team, new investigational drugs could have a significant impact on the treatment landscape.

Pharmacy managers must not only possess high levels of emotional intelligence, but should also encourage development among staff that facilitates more effective and creative outlets for frustration.

A review of the efficacy of HER2-positive–targeted agents for metastatic breast cancer.

For the study, the research team modeled COVID-19 transmission rates and the optimal allocation of an initially limited vaccine supply in the United States under a variety of scenarios.

Although the technology to remotely connect physician and patient has been in place for years, its use was limited until the spread of COVID-19.

Two-thirds of surveyed physicians said patients are presenting with more late-stage cancers, with 73% saying patients in their practice are not receiving screenings.

Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.

Health System Owned Specialty Pharmacy Alliance issues open letter outlining three needed industry actions to improve patient care and outcomes.

OTC Cases around the Common Cold for March 2021.

The oncology space has seen rapid growth in the last decade, with new approvals and indications necessitating expertise in areas such as medication use, safe practices, and reimbursement practices.

Hager Hanon, PharmD, RPh, senior pharmacist at Community Care Rx, discusses COVID-19 vaccination hesitancy among pregnant women and people with a history of anaphylaxis.

Some drugs commonly used for psoriasis can increase the risk of cardiovascular diseases, whereas other treatments can reduce the risk.

Further, the findings indicate that rapid screens can predict infection with nearly the same precision as antibody tests conducted in a lab, which could be useful for providers.

The device remains the same, but will have a larger cartridge that contains 4, 1 mg doses.

Patients with lupus who have lower vitamin D levels are more likely to have metabolic syndrome and insulin resistance, both of which are linked to heart disease, according to a new study published in Rheumatology.

Understanding breast cancer and which patients may be more vulnerable to long-term treatment effects and which patients may benefit most, can help oncologists design the best personalized neoadjuvant and adjuvant human epidermal growth factor receptor 2 (HER2)-targeted therapy.

Data have demonstrated that some patients with type 1 diabetes have resorted to unregulated DIY systems for disease management due to frustrations with slow progress made by health care providers in the management of their disease.